StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.08−0.26 (-3.54%)

Close on Nov 17, 2026Market cap $258.65MP/E –Yield –

Profound Medical net income

Net income is the profit left for shareholders after every expense, interest and tax.

Profound Medical's net income for the twelve months ending Jun 30, 2026 was -$32.75M. For fiscal 2025 it was -$42.57M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$42.57M–
FY2024Dec 31, 2024-$27.82M–
FY2023Dec 31, 2023-$28.32M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.54M–
Q1 FY2026Mar 31, 2026-$7.05M–
Q4 FY2025Dec 31, 2025-$8.18M–
Q3 FY2025Sep 30, 2025-$7.98M–
Q2 FY2025Jun 30, 2025-$15.70M–
Q1 FY2025Mar 31, 2025-$10.72M–
Q4 FY2024Dec 31, 2024-$4.95M–
Q3 FY2024Sep 30, 2024-$9.37M–
Q2 FY2024Jun 30, 2024-$6.92M–
Q1 FY2024Mar 31, 2024-$6.59M–

More Profound Medical figures

See a number that looks wrong?